NASDAQ:SYRE | Net Income | Spyre Therapeutics, Inc.

Complete source-backed net income history.

Available history
2014-12-31 to 2026-06-30
Data captured

Historical Net Income

DateNet Income
2026-06-30-$36.2M
2026-03-31-$69.01M
2025-12-31-$62.53M
2025-09-30-$11.18M
2025-06-30-$36.72M
2025-03-31-$44.77M
2024-12-31-$56.3M
2024-09-30-$69.03M
2024-06-30-$38.84M
2024-03-31-$43.86M
2023-12-31-$63.18M
2023-09-30-$40.11M
2023-06-30-$217.08M
2023-03-31-$18.42M
2022-12-31-$18.82M
2022-09-30-$18.23M
2022-06-30-$22.32M
2022-03-31-$24.44M
2021-12-31-$20.45M
2021-09-30-$20.31M
2021-06-30-$6.83M
2021-03-31-$18.22M
2020-12-31-$22.71M
2020-09-30-$18.03M
2020-06-30-$21.42M
2020-03-31-$18.73M
2019-12-31-$21.5M
2019-09-30-$21.57M
2019-06-30-$18.02M
2019-03-31-$17.17M
2018-12-31-$14.9M
2018-09-30-$11.92M
2018-06-30-$9.41M
2018-03-31-$8.12M
2017-12-31-$6.48M
2017-09-30-$7.87M
2017-06-30-$6.63M
2017-03-31-$6.25M
2016-12-31-$5.48M
2016-09-30-$6.24M
2016-06-30-$5.43M
2016-03-31-$4.55M
2015-12-31-$3.99M
2015-09-30-$3.41M
2015-06-30-$1.43M
2015-03-31-$2.47M

Annual Net Income

DateNet Income
2025-12-31-$155.2M
2024-12-31-$208.02M
2023-12-31-$338.79M
2022-12-31-$83.82M
2021-12-31-$65.8M
2020-12-31-$80.89M
2019-12-31-$78.25M
2018-12-31-$44.35M
2017-12-31-$27.24M
2016-12-31-$21.7M
2015-12-31-$11.3M
2014-12-31-$10.35M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.